DRJI, Citefactor, Journal TOC, Google Scholar

Editorial Policies

Focus and Scope

Research & Reviews: Journal of Oncology and Hematology (RRJoOH) is focused towards the publication of current research work carried out at all the major research centers in the fields of Oncology and Haematology.

Focus and Scope Covers

Oncology

  • Radiation Oncology.
  • Surgical Oncology.
  • Medical Oncology.
  • Interventional Oncology.
  • Gynecologic Oncology.
  • Pediatric Oncology.
  • Allergooncology.
  • Clinical Oncology.
  • Ocular Oncology.

Hematology

  • Erythrocytes.
  • Leukocytes and Hematopoiesis.
  • Hemostasis.
  • Thrombosis and Vascular Biology.
  • Hematological Malignancies,
  • Transplantation.

 

Section Policies

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Research Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Study

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Short Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

This Journal is managed by two executive bodies namely ‘Editorial board’ and the ‘Publication Management Team’. The ‘Editorial board’ of Journal comprises of a team of subject experts, nominated/ appointed by STM JOURNALS. Director STM JOURNALS is empowered to nominate/ appoint the editors. The editorial board of the Journal, over and above the outside experts, may have a couple of subject experts from the STM JOURNALS.
The ‘Publication Management Team' comprises of the Chairman [Director, (STM JOURNALS), India], and his support team- comprising of senior executives from STM JOURNALS and local/ out side subject experts appointed/ nominated by him.'Publication Management Team' may also have a representation of subject experts from the aforesaid 'Editorial board'.
The Chairman of the Publication Management Team of the Journal is empowered to nominate new members or dismiss the existing members of the Editorial Board and the Publication Management Team. The nomination of members is based on the knowledge, experience and their contribution in the said area of Journal and its allied branches. On the contrary, the dismissal is justified (with or without notice) on the grounds of their non- response, non-availability for longer times (without any intimation to the STM JOURNALS), non-contribution and objectionable act/ behaviour or a voluntary submission/ request to quit.
The 'Editorial board' is the competent authority in taking decision (s) on selection or rejection of the manuscripts of all the research/ review/ similar articles submitted to the Journal.The decision taken by Editors/ Reviewers is final in all respects and no further comments/ communications from authors in this regard is expected/ entertained.
In exceptional cases where it is difficult to arrive at a consensus, Publication Management Team's decision is taken as final.

 

Issue Purchase

Readers without a subscription may still purchase individual issues. The following payment options and fees are available.

Purchase an Issue: 90.00 (USD)

 

Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Purchase Article: 30.00 (USD)

The payment of this fee will enable you to view, download, and print this article.

 

Research & Reviews: Journal of Oncology and Hematology

Research & Reviews: Journal of Oncology and Hematology (RRJoOH) is focused towards the publication of current research work carried out at all the major research centers in the fields of Oncology and Haematology.

Focus and Scope Covers

Oncology

  • Radiation Oncology.
  • Surgical Oncology.
  • Medical Oncology.
  • Interventional Oncology.
  • Gynecologic Oncology.
  • Pediatric Oncology.
  • Allergooncology.
  • Clinical Oncology.
  • Ocular Oncology.

Hematology

  • Erythrocytes.
  • Leukocytes and Hematopoiesis.
  • Hemostasis.
  • Thrombosis and Vascular Biology.
  • Hematological Malignancies,
  • Transplantation.
  • Cell Therapy.